Tema Cardiovascular and Metabolic ETF
ETFYour view on HRTS
Tema Cardiovascular and Metabolic ETF
ETFTemaSentiment
AUM (USD)
$53.66M
Expense Ratio
0.99%
Holdings
46
Sentiment
Overview for Tema Cardiovascular and Metabolic ETF
- Fund Type
- ETF
- Fund Issuer
- Tema
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- November 20, 2023
- Domicile
- US
- Website
- temaetfs.com/hrts
- Fund Type
- ETF
- Fund Issuer
- Tema
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- November 20, 2023
- Domicile
- US
- Website
- temaetfs.com/hrts
- Fund Type
- ETF
- Fund Issuer
- Tema
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- November 20, 2023
- Domicile
- US
- Website
- temaetfs.com/hrts
About this fund
The Tema Heart & Health ETF (HRTS) seeks to invest in companies that potentially stand to benefit from advances in biotechnology and healthcare, specifically companies involved in cardiology, metabolic diseases and weight loss therapies.
HRTS Stock Price
Key Facts
EquityExpense Ratio
0.99%
AUM
$53.66M
Fund Details
Expense Ratio
0.99%
Assets Under Management
$53.66M
NAV
$36.02 USD
Holdings
46
Average Volume
5.0K
Inception Date
November 20, 2023
Asset Class
Equity
Fund Issuer
Tema
Domicile
US
ISIN
US87975E8839
CUSIP
87975E883
NAV Currency
USD
Expense Ratio
0.99%
Assets Under Management
$53.66M
NAV
$36.02 USD
Holdings
46
Average Volume
5.0K
Inception Date
November 20, 2023
Asset Class
Equity
Fund Issuer
Tema
Domicile
US
ISIN
US87975E8839
CUSIP
87975E883
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.